Navigation Links
ImmunoVaccine Technologies Receives $3 Million From ACOA

HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a clinical stage vaccine development company, will receive $3 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF). This funding will enable IVT to undertake a $6 million project to develop new potent immune enhancement systems.

"Having ACOA recognize the market potential of our innovative vaccine platform is a tremendous boost," commented Brian Lowe, Vice President of IVT. "This funding will enable us, over the next three years, to create novel vaccines for the treatment of cancer and infectious diseases.

This funding announcement is the maximum grant awarded to a private company under Round V of the AIF. The funds will further IVT's research collaborations and commercialization opportunities with pharmaceutical companies worldwide.

Atlantic Innovation Fund investments were announced earlier today by The Honourable Peter MacKay, Minister of National Defence and Minister of the Atlantic Canada Opportunities Agency. The Atlantic Innovation Fund is designed to increase leading edge research and development (R&D) in Atlantic Canadian research facilities, leading to the launch of new ideas, products, processes and services.

About the VacciMax(R) Platform

ImmunoVaccine Technologies Inc. (IVT) has developed a breakthrough vaccine-enhancement technology - the VacciMax(R) platform. It is comprised of a mixture of liposomes and adjuvants. The VacciMax(R) platform is able to stimulate an earlier, more powerful, long lasting immune response that could provide a new way to treat a wide range of diseases.

The opportunities for market applications and medical benefits for the VacciMax(R) platform are broad, and include prostate, breast, cervical, ovarian, colon and lung cancer treatments, as well as vaccines for pandemic influenza and other infectious diseases.

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.
2. National report calls for more research on health effects of wireless technologies
3. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
4. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
5. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
6. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
7. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
8. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
9. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies
10. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
11. BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens, Greece
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: